In This Article
The short answer: Not all body fat carries the same risk. Visceral fat, the fat packed around your liver, pancreas, and intestines inside the abdominal cavity, drains directly into the liver and is tied to insulin resistance and inflammation. Subcutaneous fat, the fat under your skin, is far less metabolically active and in some research contexts looks closer to neutral. Two people can share the same weight and BMI and carry very different amounts of each, which is why waist circumference and waist-to-height ratio tell you something the scale cannot.
- Visceral vs. Subcutaneous Fat
- Why Location Matters
- How to Estimate Which You Have
- The BMI Misconception
- What Actually Reduces It
- FAQ
- Key Takeaways
- References
Read key takeaways →
Visceral vs. Subcutaneous Fat: What Is Actually Different
Body fat is not one tissue in one place. Subcutaneous fat sits just under the skin across the body, on the hips, thighs, arms, and the outer abdominal wall. Visceral fat is stored deeper, inside the abdominal cavity, wrapped around the liver, pancreas, and intestines. You can pinch subcutaneous fat between your fingers. Visceral fat is internal and cannot be pinched, which is part of why two people with similar body fat percentages can look different and carry very different metabolic risk.
Two Fat Depots, Two Different Roles
Subcutaneous fat
- Located under the skin
- Makes up most of total body fat
- Drains into general systemic circulation
- Weaker link to metabolic disease in most research
Visceral fat
- Located deep in the abdominal cavity
- Surrounds the liver, pancreas, and intestines
- Drains directly into the liver via the portal vein
- Strongly linked to insulin resistance and inflammation
Why Visceral Fat Carries More Metabolic Risk
Location changes function. Per Björntorp's 1990 portal theory, published in Arteriosclerosis, visceral fat sits close enough to the portal vein that the free fatty acids and signaling molecules it releases travel straight to the liver before reaching the rest of the body. Subcutaneous fat drains into general circulation instead, where its output gets diluted before it reaches any single organ.
The Portal Vein Pathway
Visceral fat releases fatty acids and cytokines
Enlarged visceral fat cells secrete more inflammatory signaling molecules than subcutaneous fat cells of the same size.
The portal vein carries that output straight to the liver
Fontana and colleagues (2007) sampled portal vein and radial artery blood during gastric bypass surgery in obese patients and found portal vein interleukin-6 running roughly 50 percent higher than in the radial artery, correlating with systemic C-reactive protein.
The liver responds with inflammation and altered lipid handling
This portal exposure is a proposed driver of the insulin resistance and dyslipidemia that cluster with abdominal obesity.
Després and Lemieux, in a 2006 review in Nature, describe abdominal obesity as a marker of dysfunctional adipose tissue and place it at the center of metabolic syndrome, alongside insulin resistance and inflammation markers you can track in wearable and blood data. Subcutaneous fat does not appear to carry the same weight in that framework.
This does not mean subcutaneous fat is harmless at any amount, or that visceral fat is the only variable that matters. Tran and colleagues (2008) transplanted subcutaneous fat into the visceral cavity of mice and found it improved insulin sensitivity and glucose handling, while transplanted visceral fat did not. That is animal research, not a human clinical trial, so treat it as mechanistic support for a location-based effect rather than a rule you can apply directly to your own body.
How to Estimate Which One You Have Without a Scan
A DEXA or CT scan is the direct way to measure visceral fat, but most people do not have regular access to one. Pouliot and colleagues, in a 1994 study in The American Journal of Cardiology, compared several simple anthropometric measures against CT-measured visceral fat and found that waist circumference and the abdominal sagittal diameter were better simple correlates of visceral fat than the older waist-to-hip ratio.
Waist-to-height ratio under about 0.5
Used as a simple heuristic, not a diagnostic cutoff, in the screening literature reviewed by Ashwell and colleagues (2012).
Waist-to-height ratio approaching or above 0.5
Associated in pooled studies with higher cardiometabolic risk, though individual risk still depends on many other factors.
Rising waist measurement at a stable body weight
A practical signal that fat distribution may be shifting toward the abdomen even if the scale is not moving.
Ashwell, Gunn, and Gibson, in a 2012 systematic review and meta-analysis in Obesity Reviews, concluded that waist-to-height ratio screened for cardiometabolic risk factors better than waist circumference alone or BMI, pooling data across a large number of studies. A simple tape measure at the navel, tracked over time and read alongside your body composition trend, is a more useful signal than weight alone.
The Misconception: Same BMI Does Not Mean Same Risk
Misconception: BMI tells you what you need to know about fat-related risk. Yusuf and colleagues, in the 2005 INTERHEART case-control study published in The Lancet across more than 27,000 participants in 52 countries, found that waist-to-hip ratio was strongly and consistently associated with heart attack risk worldwide, while BMI was only weakly associated once other factors were considered. Two people can share an identical BMI and carry very different amounts of visceral fat, and therefore very different risk.
This is the core reason a scale weight or a BMI number is a weak stand-in for fat distribution. It cannot distinguish a person carrying most of their fat subcutaneously from a person carrying more of it viscerally, even at the exact same total weight.
What Actually Reduces Visceral Fat
Aerobic exercise, even without much weight loss
Ross and colleagues, in a 2000 randomized controlled trial in Annals of Internal Medicine, found that an exercise program without significant weight loss still reduced visceral fat in obese men, while diet-induced and exercise-induced weight loss of similar magnitude produced comparable reductions in both visceral and subcutaneous fat.
A sustained caloric deficit
Weight loss from a caloric deficit reduces both fat depots; the trial above found visceral fat responding at least as readily as subcutaneous fat to that deficit, whether it came from diet or exercise.
Tracking the waist, not just the scale
Because BMI and total weight cannot separate the two fat depots, a monthly waist-to-height ratio reading is a more direct way to see whether abdominal fat specifically is trending down.
Frequently Asked Questions
Can I have a normal BMI and still have too much visceral fat?
Yes. Yusuf and colleagues (2005) found waist-to-hip ratio was strongly tied to heart attack risk worldwide while BMI was only weakly associated, which is direct evidence that BMI alone misses fat distribution. This pattern is sometimes described elsewhere as normal-weight obesity.
Why is visceral fat considered worse than subcutaneous fat?
Mainly location. Visceral fat drains directly into the liver through the portal vein, so its fatty acid and cytokine output reaches the liver at a higher concentration than subcutaneous fat's output does, per the portal theory Bjorntorp described in 1990 and the direct portal vein sampling by Fontana and colleagues (2007).
What is a reasonable waist-to-height ratio to aim for?
Ashwell and colleagues' (2012) meta-analysis supports roughly 0.5 as a simple screening heuristic, meaning a waist circumference under about half your height. Treat it as a general guide rather than a precise medical cutoff, since individual risk depends on many other factors too.
Do I need a DEXA or CT scan to know how much visceral fat I have?
Not for a general estimate. Pouliot and colleagues (1994) found waist circumference to be a strong simple proxy for CT-measured visceral fat, so a consistent waist measurement tracked over time is a reasonable substitute for most people.
Does exercise reduce visceral fat even if I do not lose weight on the scale?
It can. Ross and colleagues (2000) found that an exercise program without significant weight loss still reduced visceral fat in obese men in a randomized controlled trial, which suggests the scale is not the only signal worth watching.
Is subcutaneous fat completely harmless?
No, but the evidence generally ties it less strongly to metabolic disease than visceral fat. Tran and colleagues' (2008) mouse transplant study found subcutaneous fat placed in the visceral cavity improved metabolic markers, hinting at a real location effect, though that is animal data and should not be read as proof subcutaneous fat carries zero risk in humans.
What to Remember
- →Visceral fat surrounds internal organs and drains directly into the liver through the portal vein, while subcutaneous fat sits under the skin and drains into general circulation (Bjorntorp, 1990).
- →Direct portal vein sampling during surgery found visceral fat's inflammatory signaling reaching the liver at meaningfully higher concentrations than in general circulation (Fontana et al., 2007).
- →BMI does not reliably separate the two: the INTERHEART study found waist-to-hip ratio far more strongly tied to heart attack risk worldwide than BMI (Yusuf et al., 2005).
- →Waist circumference and waist-to-height ratio are reasonable simple proxies for visceral fat when a DEXA or CT scan is not available (Pouliot et al., 1994; Ashwell et al., 2012).
- →A waist-to-height ratio near or under 0.5 is a useful screening heuristic, not a precise medical cutoff (Ashwell et al., 2012).
- →Exercise can reduce visceral fat even without major weight loss, and a caloric deficit from either diet or exercise reduces both fat depots (Ross et al., 2000).
Related on Protocol
What Insulin Resistance Looks Like in Your Wearable Data Before You Know You Have It
How the same visceral fat and liver signaling described here shows up early in your daily data
How to Use Your Wearable Data to Optimize Fat Loss Without Muscle Loss
How to structure a caloric deficit that favors fat loss, including abdominal fat, over muscle
How to Interpret Your Lipid Panel: LDL Particles, ApoB, and What Actually Matters
The bloodwork side of the same metabolic risk that visceral fat drives
Track your waist trend alongside the rest of your health data
Protocol lets you log body measurements next to your training, sleep, and recovery data, so you can see whether abdominal fat is actually trending down, not just total weight.
Get started freeReferences
Key Researchers
- Jean-Pierre Despres (Laval University) Lead author on multiple foundational studies linking abdominal fat distribution to metabolic syndrome and cardiovascular risk.
- Per Bjorntorp (University of Gothenburg) Originated the portal vein theory explaining why visceral fat carries more metabolic risk than subcutaneous fat.
- Samuel Klein (Washington University in St. Louis) Senior author on the direct portal vein sampling study linking visceral fat to systemic inflammation.
Key Studies
- Despres and Lemieux (2006) Nature. Review describing abdominal obesity as a marker of dysfunctional adipose tissue central to metabolic syndrome.
- Bjorntorp (1990) Arteriosclerosis. Proposed the portal vein pathway by which visceral fat output reaches the liver before dilution in general circulation.
- Fontana et al. (2007) Diabetes. Found portal vein interleukin-6 running roughly 50 percent higher than radial artery levels in obese surgical patients, correlating with systemic inflammation.
- Pouliot et al. (1994) The American Journal of Cardiology. Found waist circumference and abdominal sagittal diameter to be better simple correlates of CT-measured visceral fat than waist-to-hip ratio.
- Ashwell, Gunn, and Gibson (2012) Obesity Reviews. Systematic review and meta-analysis finding waist-to-height ratio screens cardiometabolic risk better than waist circumference or BMI alone.
- Yusuf et al. (2005) The Lancet. The INTERHEART case-control study of more than 27,000 participants in 52 countries, finding waist-to-hip ratio far more strongly tied to heart attack risk than BMI.
- Ross et al. (2000) Annals of Internal Medicine. Randomized controlled trial finding exercise without significant weight loss still reduced visceral fat in obese men.
- Tran et al. (2008) Cell Metabolism. Mouse transplant study finding subcutaneous fat placed in the visceral cavity improved insulin sensitivity, while transplanted visceral fat did not.
